Investment Firm Adds Nearly $4 Million in DYN Shares
A major investment firm boosted its Dyne Therapeutics stake by nearly $4 million, highlighting renewed interest in DY...
Assess the pros and cons of emergency versus sinking funds to determine which is more suitable for your goals, and how to combine them effectively.
23,964 articlesA major investment firm boosted its Dyne Therapeutics stake by nearly $4 million, highlighting renewed interest in DY...
A billionaire hedge fund manager shows the power of high-conviction bets in AI. This article breaks down Ackman'...
Quarterly filings reveal big-money moves. Seven of eight ultra-rich fund managers trimmed a single AI stock that’s su...
David Tepper accelerates a $400 million macro bet pairing a country ETF with a memory-chip giant, underscoring what s...
Active ETFs are reshaping how people think about investing. This article explains what they are, when they can beat p...
A top institutional trader doubled down on PTCT, adding thousands of shares in a high-conviction move. This analysis ...
A bipartisan proposal aims to cap Social Security benefits for the wealthiest couples to address long-term solvency c...
USO has surged nearly 100% this year as Hormuz shutdowns persisted. A reopening could spark a swift unwind.
Four billionaire investors from divergent strategies quietly increased bets on a leading chipmaker, signaling a broad...
Vertex is pursuing Crinetics with a substantial all-cash offer. This deep dive breaks down what the $10 billion bid m...
Uncover what historically cheap ultra-high-yield dividend opportunities look like, why prices swing, and how to build...
Policy watchers say a White House-backed regulatory milestone could open crypto and private equity to trillions in re...